Merck
Executive Summary
Judy Lewent elected to VP-finance and chief financial officer, Merck said March 29, reportedly making her the first woman to be appointed as the top financial officer for a major U.S. corporation. Lewent joined Merck in 1980 as director of acquisitions and capital analysis. Most recently, she was named VP and treasuer in 1987. Lewent will continue to report to Senior VP Francis Spiegel, Jr. Succeeding her as treasurer is Michael Atieh, who has been the VP for government relations in Merck's Washington, D.C. office for two years. Teel Oliver, who has been in Merck's Washington office since 1984, will be Atieh's successor and will carry the title of VP-governmental relations.
You may also be interested in...
Irish Body Sets Out Five-Year Vision Strategy For Off-Patent Sector
With a focus on drug accessibility, supply chain resilience, and a balanced approach to sustainability, Medicines for Ireland “calls to action” with its five-year plan.
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.
Dr Reddy’s Knocked Back On Rituximab In US
Dr Reddy’s has received a complete response letter from the US FDA, knocking back its proposed rituximab biosimilar rival to Rituxan.